NASDAQ: GLYC
Glycomimetics Inc Stock Ownership - Who owns Glycomimetics?

Insider buying vs selling

Have Glycomimetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Invus Public Equities LP10% Owner2024-08-08260,873$0.19
$50.09kSell
Invus Public Equities LP10% Owner2024-08-0761,488$0.18
$11.19kSell
Invus Public Equities LP10% Owner2024-08-0655,732$0.18
$10.20kSell
Invus Public Equities LP10% Owner2024-08-05164,523$0.19
$30.93kSell
Invus Public Equities LP10% Owner2024-08-02286,200$0.20
$57.24kSell
Invus Public Equities LP10% Owner2024-08-0163,564$0.22
$13.73kSell
Invus Public Equities LP10% Owner2024-07-30756,835$0.22
$167.26kSell
Invus Public Equities LP10% Owner2024-07-29363,949$0.24
$85.53kSell
Invus Public Equities LP10% Owner2024-07-26258,335$0.24
$62.52kSell
Edwin RockChief Medical Officer2024-06-21115,000$0.27
$30.71kBuy

1 of 2

GLYC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLYC insiders and whales buy or sell their stock.

GLYC Shareholders

What type of owners hold Glycomimetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott D. Sandell21.80%14,056,571$3.67MInsider
M. James Barrett20.44%13,182,418$3.44MInsider
Peter J. Barris20.44%13,182,418$3.44MInsider
Bvf Inc14.80%9,544,262$2.49MInstitution
Siren LLC13.32%8,589,064$2.24MInsider
Invus Public Equities LP9.80%6,317,565$1.65MInsider
New Enterprise Associates 10 L P7.75%4,995,664$1.30MInsider
New Enterprise Associates 13 LP6.35%4,093,377$1.07MInsider
Vanguard Group Inc4.14%2,670,208$696.92kInstitution
Siren LLC3.05%1,965,114$512.89kInstitution

1 of 3

GLYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLYC20.19%79.81%Net Selling
BOLT48.48%51.52%
APRE3.26%96.74%Net Buying
CRVO4.87%95.13%Net Buying
MEIP15.88%84.12%Net Buying

Glycomimetics Stock Ownership FAQ

Who owns Glycomimetics?

Glycomimetics (NASDAQ: GLYC) is owned by 27.59% institutional shareholders, 109.07% Glycomimetics insiders, and 0.00% retail investors. Scott D. Sandell is the largest individual Glycomimetics shareholder, owning 14.06M shares representing 21.80% of the company. Scott D. Sandell's Glycomimetics shares are currently valued at $3.88M.

If you're new to stock investing, here's how to buy Glycomimetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.